logo
3 teens invented a salt-powered refrigerator that doesn't need electricity. They're building 200 of them for hospitals to use.

3 teens invented a salt-powered refrigerator that doesn't need electricity. They're building 200 of them for hospitals to use.

Yahoo16-04-2025
Three teens built a salt-powered fridge to help bring vaccines and medical supplies to rural areas.
The invention uses salts that pull heat from their environments when they dissolve in water.
They won the 2025 Earth Prize of $12,500 and plan to test 200 units in 120 hospitals.
Three teenagers designed a mini refrigerator that cools itself with salt and doesn't require an outlet. They're bringing it to hospitals to help transport medical supplies to rural areas without electricity.
Dhruv Chaudhary, Mithran Ladhania, and Mridul Jain live in Indore, India and all have parents working in medical fields. The boys decided to find a salty refrigeration technique after hearing how challenging it was to bring COVID-19 vaccines to rural areas without electricity.
Their invention, which they call Thermavault, won them the 2025 Earth Prize on Saturday. The award comes with $12,500, which they plan to use to build 200 of their refrigerators and send them to 120 hospitals for testing.
They hope their refrigerator can help transport vaccines, other medicines and supplies, and even transplant organs.
"We have been able to keep the vaccines inside the Thermavault for almost 10 to 12 hours," Dr. Pritesh Vyas, an orthopedic surgeon who tested the device at V One hospital in Indore, says in a video on the Thermavault website.
With some improvements like a built-in temperature monitor, he added, "it will be definitely helpful, definitely useful in the remote places, the villages."
Some salts can have a cooling effect when they're dissolved in water.
That's because when those salts dissolve, the charged atoms, or ions, that make them up break apart. That separation requires energy, which the ions pull from the environment, thus cooling the water around them.
Chaudhary, Ladhania, and Jain searched the internet, first compiling a list of about 150 salts that might work, then narrowing it down to about 20 that seemed most efficient.
They then borrowed a lab at the Indian Institutes of Technology to test those 20, or so. To their disappointment, none of the salts cooled the water enough.
They were back to square one. Turns out, they didn't need the internet after all — their school teacher recommended trying two different salts: barium hydroxide octahydrate and ammonium chloride.
"While we did scour through the entire internet to find the best salt possible, we kind of just ended up back to our ninth-grade science textbook," Chaudhary said.
The trio says they found that ammonium chloride maintained temperatures of around 2 to 6 degrees Celsius (about 35 to 43 degrees Fahrenheit), which is ideal for many vaccines. Adding barium hydroxide octahydrate to the mix produced sub-zero Celsius temperatures, which is ideal for some other vaccines and sometimes for transplant organs.
Now they had two different refrigeration options.
About three months later, they'd built a prototype and were testing it in local hospitals.
The fridge itself is an insulated plastic container with a copper wall lining the inside, where the vaccines or organs would sit. The cooling solution, made by dissolving the salts in water, is poured into a space between the plastic outer wall and the copper inner wall.
Cold boxes and coolant packs are already in widespread use for bringing vaccines to rural areas without electricity. Those carriers typically rely on simple ice packs.
One advantage of the ammonium chloride solution, the trio of teens says, is it's reusable in the field without electricity. You don't need a freezer to pull ice from. Rather, you can remove the salt water from the box, boil away the water, and collect the salt in its solid form, ready to dissolve in new water and produce its cooling effect all over again.
Jain said they're planning to use the prize money to pursue a Performance, Quality and Safety (PQS) certification through the World Health Organization so they can pitch it to Gavi — an international alliance that distributes vaccines.
The Earth Prize program also has a volunteer who can help them pursue a patent, according to a spokesperson.
The Earth Prize casts across the planet for teens who are working on environmental projects and awards one winner from each world region. Chaudhary, Ladhania, and Jain won the prize for Asia. A global winner will be chosen by public vote, which closes on April 22.
Read the original article on Business Insider
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Researchers find premature aging in blood vessels of COVID-19 patients
Researchers find premature aging in blood vessels of COVID-19 patients

UPI

time28 minutes ago

  • UPI

Researchers find premature aging in blood vessels of COVID-19 patients

Researchers at Université Paris Cité in France conducted a study that suggests COVID-19 infections cause women's blood vessels to age prematurely. File Photo by Shou Sheng/EPA COVID-19 infection appears to cause women's blood vessels to age prematurely, potentially increasing their risk of heart disease, a new study says. Women infected with COVID-19 experienced about five additional years of blood vessel aging, even if they had a mild case, according to results published Aug. 17 in the European Heart Journal. If a woman landed in the intensive care unit with severe COVID, her blood vessels received up to 10 years of premature aging, results show. "We know that COVID can directly affect blood vessels. We believe that this may result in what we call early vascular aging, meaning that your blood vessels are older than your chronological age and you are more susceptible to heart disease," lead researcher Dr. Rosa Maria Bruno, a professor of clinical pharmacology at Université Paris Cité in France, said in a news release. "If that is happening, we need to identify who is at risk at an early stage to prevent heart attacks and strokes," Bruno added. Men also experienced blood vessel aging as a result of COVID-19 infection, but the effect was not statistically significant among the participants studied, researchers report. For the study, researchers tested 2,400 people from 16 countries recruited between September 2020 and February 2022. The participants included people not infected by COVID-19, as well as COVID-19 patients who didn't require hospitalization, were treated in a hospital or had an infection severe enough to require time in an intensive care unit. Researchers assessed each person's vascular age with a device that measures how quickly a wave of blood pressure travels between the carotid artery in the neck and the femoral arteries of the legs. This measurement is called carotid-femoral pulse wave velocity. The higher this number, the stiffer and older a person's blood vessels have become, researchers said. Measurements taken six months and a year after a person's COVID-19 infection showed that all three groups had stiffer arteries compared to those who were never infected: The average increase in PWV was 0.55 meters per second for women who had mild COVID-19 and 0.6 meters per second for women hospitalized with COVID-19. For women treated in an ICU, the average increase in PWV was 1.09 meters per second. Researchers said an increase of about 0.5 meters per second is "clinically relevant" and equivalent to aging of around five years. For example, it would increase risk of heart disease by about 3% in a 60-year-old woman. People who had persistent symptoms of long COVID-19, such as shortness of breath or fatigue, were more likely to have prematurely aged arteries, researchers said. In fact, this effect on the arteries might help explain some of the long COVID-19 symptoms reported by as many as 40% of COVID-19 patients, Dr. Behnood Bikdeli, a cardiologist at Harvard Medical School, noted in an accompanying editorial. "Vascular injury -- marked by endothelial dysfunction, inflammation and coagulation abnormalities -- is a key mechanism driving these complications," Bikdeli wrote. On the other hand, people who had been vaccinated against COVID-19 generally had arteries that were less stiff compared to the unvaccinated. There are several potential explanations for why COVID-19 might cause premature stiffening in the arteries, Bruno said. "The COVID-19 virus acts on specific receptors in the body, called the angiotensin-converting enzyme 2 receptors, that are present on the lining of the blood vessels," she said. "The virus uses these receptors to enter and infect cells. This may result in vascular dysfunction and accelerated vascular aging." Bruno said the body's inflammation and immune responses, defenses against infection, may also be involved. Immune response might also explain the difference between women and men, she said. "Women mount a more rapid and robust immune response, which can protect them from infection," Bruno said. "However, this same response can also increase damage to blood vessels after the initial infection." Doctors should perform vascular aging tests on COVID-19 patients and treat those affected with drugs to lower their blood pressure and cholesterol, Bruno said. Lifestyle changes such as a healthy diet and regular exercise also can help protect their heart health. "For people with accelerated vascular aging, it is important to do whatever possible to reduce the risk of heart attacks and strokes," Bruno said. The researchers plan to continue following participants to see whether their accelerated vascular aging actually leads to an increased risk of heart attack and stroke. More information The U.S. Centers for Disease Control and Prevention has more on long COVID. Copyright © 2025 HealthDay. All rights reserved.

Time-Lapse Shows Iran's Largest Lake Shrinking in Drought Crisis
Time-Lapse Shows Iran's Largest Lake Shrinking in Drought Crisis

Newsweek

time4 hours ago

  • Newsweek

Time-Lapse Shows Iran's Largest Lake Shrinking in Drought Crisis

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Lake Urmia, once the world's second-largest saltwater lake, has shrunk drastically, leaving salt-encrusted marshes and barren flats in its southern region. Its decline reflects deeper challenges facing Iran. Iran is enduring a historic drought, crippling energy shortages, and relentless heat waves with temperatures regularly surpassing 40 degrees Celsius (104 degrees Fahrenheit). Offices and schools in Tehran close intermittently to conserve power, while residents suffer without air conditioning. Rising frustration over these hardships has sparked protests, showing how environmental collapse and infrastructure failures are driving public unrest. Newsweek reached out to Iran's Foreign Ministry for comment. Why It Matters Frustration is mounting across Iran as drought, power shortages, and scorching heat push citizens to the brink. The collapse of Lake Urmia, once a symbol of national pride, underscores the consequences of environmental neglect and policy failures. Its decline highlights how climate pressures and governance shortcomings can destabilize both ecosystems and communities, turning ecological loss into a broader crisis of public trust and political legitimacy. Images captured by the ESA's Sentinel-2 satellites on in May 2020, left, and August 2025 show the declining water levels of Iran's Lake Urmia. Images captured by the ESA's Sentinel-2 satellites on in May 2020, left, and August 2025 show the declining water levels of Iran's Lake Urmia. Copernicus What To Know The scale of Urmia's collapse is visible from above. A time-lapse of satellite images, captured by the European Space Agency's Sentinel-2 satellites, part of its Copernicus Earth observation program, taken between 2020 and 2025, shows the southern portion shrinking year after year, leaving behind desolate salt crusts where vibrant waters once drew tourists. Once a thriving ecosystem supporting wildlife and local commerce, the area now stands as a testament to the combined impact of drought, overuse, and poor management. Tehran Suffers The human consequences are immediate. In Tehran, government offices close on some days to conserve energy, leaving workers sweltering in uncooled rooms. Hospitals face blackouts so severe that medics fan chemotherapy patients in pitch darkness. These scenes have fueled small but vocal protests. In Rasht, demonstrators chanted demands for water and electricity as police stood by, while in Babolsar, residents gathered outside a power station to denounce the relentless outages. An image of the Babolsar protest, shared by X user Nassem Aslam, purports to show crowds assembled outside the facility. IRAN PROTESTS ERUPT OVER BLACKOUTS AND WATER TRANSFERS In Babolsar, angry residents surrounded the city's governmental building after enduring daily power cuts of 6–8 hours, leaving them without water, internet, or mobile service. The unrest reflects mounting frustration over… — Naeem Aslam (@NaeemAslam23) August 16, 2025 Post-War Crisis The crisis is unfolding against the backdrop of war. In June, Israel and the United States launched a wave of airstrikes against Iran's nuclear program, targeting facilities tied to enrichment and missile development. Iran responded with missile and drone attacks on Israel, and later struck a U.S. air base in Qatar, further heightening regional tensions and marking one of the most dangerous escalations between the countries in years. Amid this heightened turmoil, Israeli Prime Minister Benjamin Netanyahu turned his attention to Iran's domestic challenges. Last week, he issued a message directed at the Iranian people, urging them to rise against their government over the power outages and water shortages and promising that Israeli technicians would come to restore electricity and water systems if the regime was overthrown. Iranian President Masoud Pezeshkian dismissed the appeal, calling it nothing more than a mirage. An Iranian girl drinks water during a heat wave in the capital Tehran on August 9, 2025. An Iranian girl drinks water during a heat wave in the capital Tehran on August 9, People Are Saying Israeli Prime Minister Benjamin Netanyahu: "Once you are free from the tyrannical regime that oppresses you, we in Israel will be happy to help the people of Iran solve the water problem, among other things, and bring back water to your lives." Iranian President Masoud Pezeshkian: "A regime that deprives people of Gaza of water and food says it will bring water to Iran? A mirage, nothing more." What Happens Next Lake Urmia's southern basin is now almost entirely desiccated, its disappearance reflecting both environmental collapse and institutional failure. For many Iranians, the drying lake has become a symbol of the daily struggles tied to water, power, and governance.

Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies
Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies

Business Wire

time5 hours ago

  • Business Wire

Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies

ROCHESTER, Minn.--(BUSINESS WIRE)-- Nucleus RadioPharma, a next-generation contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the appointment of Dr. Stephen M. Hahn as chief executive officer. Hahn's leadership signals Nucleus RadioPharma's urgency in scaling the infrastructure necessary to make minimally invasive, targeted cancer therapies accessible to patients around the world. Hahn joins Nucleus RadioPharma after serving as CEO-partner of Flagship Pioneering and CEO of Harbinger Health since 2021. He served as the 24th U.S. Food and Drug Administration (FDA) commissioner from 2019 to 2021, overseeing both COVID and non-COVID regulatory affairs. Before joining the FDA, he was the chief medical executive at MD Anderson Cancer Center in Houston. The combination of regulatory, clinical and operational knowledge gives him deep insight into how therapies move from clinic to patient. Radiopharmaceuticals represent one of the most promising frontiers in oncology​, offering treatments that are less toxic, less invasive and far more precise in targeting cancer cells. When patients receive these therapies, outcomes improve and quality of life is preserved. However, widespread access to radiopharmaceuticals remains extremely limited​, not due to scientific barriers, but logistical ones. Three interdependent issues drive these supply chain challenges: a fragile and insufficient supply of key isotopes, limited GMP-compliant infrastructure capable of handling a range of medical isotopes and an underdeveloped operational capacity to manage radioactive drugs. 'Radiopharmaceuticals are the next frontier of precision oncology care,' said Hahn. 'But without the infrastructure to deliver these treatments, their impact is fundamentally limited. At Nucleus RadioPharma, we have an extraordinary team that is committed to breaking those barriers. Together, we will scale the systems and infrastructure needed to make these lifesaving therapies available to all who need them.' Under Hahn's leadership, Nucleus RadioPharma is uniquely positioned to tackle these issues, take radiopharmaceuticals to new levels of precision and efficacy and make minimally invasive therapies the new standard for cancer treatment. 'Steve's experience as both a physician treating patients and as a leader at the FDA brings an unparalleled perspective to Nucleus as the company works to build the infrastructure needed to accelerate the widespread availability of radiopharmaceuticals,' said Justin Butler, partner at Eclipse and Nucleus board member. 'His new role is a major indicator to the oncology community that radiopharmaceuticals are the future of precision cancer treatment, and that Nucleus is poised to lead the next era.' Founded in 2022 through a collaboration between Eclipse and Mayo Clinic, Nucleus has raised $72 million in funding to date, including participation from AstraZeneca. The company is building a network of advanced facilities, starting in Mesa, Arizona, and Spring House, Pennsylvania, that integrate research, development and commercial-scale production under one roof, enabling faster, more reliable distribution to clinical trial sites and treatment centers. 'With one of the largest cancer theranostics practices in the world, we have a responsibility to drive continual innovation and develop new targeted diagnostic and therapeutic radioisotopes for our patients,' said Dr. Cheryl Willman, Stephen and Barbara Slaggie executive director for Mayo Clinic Cancer Programs and Mayo Clinic Comprehensive Cancer Center. 'With Steve's exemplary leadership skills and expertise as a cancer physician and scientist, our future could not be brighter.' In his first year as CEO, Hahn will focus on completing the company's GMP readiness at its Rochester, Minnesota, facility, expanding R&D capabilities, launching Nucleus' data platform and forging strategic partnerships. Over the next five years, the company aims to dramatically increase manufacturing capacity and advance initiatives that improve patient access worldwide. For more information on Nucleus RadioPharma, see here. Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, Nucleus provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Its technology platforms are at the forefront of radiopharmaceutical research, designed to advance new therapies through clinical trials to commercialization. Learn more at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store